Since CTLA-4 expression is dynamically regulated in the TME, these results suggest that tumors with low CTLA4 mRNA expression may have fewer CTLA-4-positive cells (activated T, Treg, and tumor cells) or a lower amount of CTLA4 expression per cell. The gene discussed is CTLA4; the disease is neoplasm.